Innovative CNS Focus Cassava Sciences specializes in developing treatments for central nervous system disorders, representing an opportunity to connect with healthcare providers and research organizations involved in neurodegenerative and neurodevelopmental treatments.
Strategic Partnerships The company's collaboration with Yale University on intellectual property rights signals potential for joint research initiatives and academic partnerships that can open doors for co-development and licensing deals.
Recent Leadership Growth Key hires such as the appointment of a Senior Vice President of Clinical Development and a new expert in preclinical programs indicate active expansion in R&D capabilities, presenting opportunities for specialized vendors and service providers.
Funding and Revenue Potential With a current funding of 50 million USD and revenues ranging up to 25 million USD, Cassava Sciences is in a growth phase, making it a promising client for investments in biotechnology tools, clinical trial services, and innovative research solutions.
Market Positioning Operating in a highly competitive biotech landscape among giants like Roche and Bristol-Myers Squibb, Cassava’s niche focus on CNS disorders offers tailored sales opportunities in specialized medical devices, biotech collaborations, and drug development partnerships.
$10B
$10B
$10B
$10B
$10B
$10B
$10B
$10B
$10B
$10B
$1B$10B
$10BCassava Sciences, Inc. uses 8 technology products and services including Open Graph, React, Web Vitals, and more. Explore Cassava Sciences, Inc.'s tech stack below.
| Cassava Sciences, Inc. Email Formats | Percentage |
| FLast@paintrials.com | 96% |
| Last@paintrials.com | 4% |
| FLast@cassavasciences.com | 41% |
| First@cassavasciences.com | 9% |
| FLast@cassavasciences.com | 41% |
| First@cassavasciences.com | 9% |
Biotechnology ResearchTexas, United States11-50 Employees
Refer to descriptions included in the Company's filings with the Securities and Exchange Commission for more information about the Company. The Company does not intend to update and does not take responsibility for any information published on LinkedIn.
Company Overview
Media & News
Funding & FinancialsCassava Sciences, Inc. has raised a total of $50M of funding over 5 rounds. Their latest funding round was raised on Nov 18, 2022 in the amount of $50M.
Cassava Sciences, Inc.'s revenue is estimated to be in the range of $10M$25M
Funding & FinancialsCassava Sciences, Inc. has raised a total of $50M of funding over 5 rounds. Their latest funding round was raised on Nov 18, 2022 in the amount of $50M.
Cassava Sciences, Inc.'s revenue is estimated to be in the range of $10M$25M
1-888-653-2347 
support@leadiq.com